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Abstract 
In May 2000, public health authorities in Dublin, Ireland, identified a cluster of unexplained 
severe illness among injecting drug users (IDUs). Similar clusters were also reported in 
Scotland and England. Concurrent investigations were undertaken to identify the aetiology 
and source of the illnesses. In Dublin, 22 IDUs were identified with injection-site 
inflammation resulting in hospitalization or death; eight (36%) died. Common clinical findings 
among patients with severe systemic symptoms included leukaemoid reaction and 
cardiogenic shock. Seventeen (77%) patients reported injecting heroin intramuscularly in the 
2 weeks before illness. Of 11 patients with adequate specimens available for testing, two 
(18%) were positive by 16S rDNA PCR for Clostridium novyi. Clinical and laboratory findings 
suggested that histotoxic Clostridia caused a subset of infections in these related clusters. 
Empiric treatment for infections among IDUs was optimized for anaerobic organisms, and 
outreach led to increased enrolment in methadone treatment in Dublin. Many unique legal, 
medical, and public health challenges were encountered during the investigation of this 
outbreak. 
INTRODUCTION 
On 19 May 2000, public health authorities in the United Kingdom reported a cluster of 
severe unexplained illnesses among injecting drug users (IDUs) in Glasgow, Scotland [1]. 
On 20 May 2000, emergency department physicians from a hospital in southwest Dublin, 
Ireland notified the coroner of an unexplained death with temporal and social links to a 
cluster of severe illnesses among IDUs. By 25 May 2000, the Eastern Regional Health 
Authority (ERHA) in Ireland had identified a total of 14 similar cases among IDUs presenting 
to this hospital [2]. Shortly thereafter, a third cluster was identified among IDUs in northwest 
England [3]. In all locations, the initial case-patients shared distinct historical and clinical 
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findings, including recent heroin use and severe soft-tissue inflammation at an injection site, 
often followed by profound leucocytosis and cardiogenic shock. Post-mortem examinations 
did not reveal a specific cause of death [4]. 
In mid-May Norwegian authorities reported that an IDU from Oslo had recently died from 
anthrax [5, 6]. The clinical presentation was very similar to the clusters identified in the 
United Kingdom and Ireland. Coupled with the expanding number of cases and severity of 
illness, this report heightened the sense of urgency to identify the cause of the outbreak. In 
response, a collaborative international investigation was initiated to (1) describe the clinical 
and epidemiological features of the case patients, (2) identify the cause of their unexplained 
illness, and (3) define a potential source of the outbreak. This paper describes the 
epidemiology of the Irish outbreak of severe illness and death in IDUs and highlights the 
unique challenges of this public health investigation. 
 
METHODS 
 Case finding 
For the purposes of this investigation, a case was defined as an IDU admitted to hospital or 
found dead in Ireland between 1 April and 31 August 2000 with severe soft-tissue 
inflammation (i.e. abscess, induration, cellulitis, fasciitis, myositis) at an injection site. Active 
and enhanced passive surveillance was conducted through inquiries to emergency 
departments, hospital pathologists, coroners’ offices and drug treatment centres in the 
ERHA. Public health alerts were also disseminated to all hospitals and general practitioners 
in Ireland and the United Kingdom. 
Data collection 
We reviewed available medical records and autopsy reports for each case-patient. Variables 
collected included patient demographics, underlying conditions, clinical signs and 
symptoms, laboratory findings, treatment, illness course, outcome, and post-mortem 
findings. Surviving patients were interviewed regarding clinical symptoms, living conditions 
and drug use practices including types and sources of drugs used, drug preparation, routes 
of injection, sharing of drugs or equipment, and recent changes in behaviour. For deceased 
patients, surrogates familiar with their routine habits and exposures were interviewed. 
Laboratory procedures and testing 
Gram stain and routine aerobic and anaerobic cultures were performed at local microbiology 
laboratories on available blood and wound samples. When possible, specimens were also 
sent to reference laboratories at the Centers for Disease Control and Prevention (CDC, 
Atlanta, GA, USA) and the Public Health Laboratory Service (PHLS, UK) for further 
diagnostic testing. 
Tissue samples were evaluated using enhanced aerobic and anaerobic culture, 
histopathology, immunohistochemistry (IHC) against group A streptococcus and Bacillus 
anthracis, and broad range bacterial 16S ribosomal DNA (16S rDNA) polymerase chain 
reaction (PCR). Enhanced aerobic and anaerobic cultures and isolate identification were 
performed based on a standard outbreak protocol [7]. Isolates identified as Clostridium spp. 
were subtyped using amplified fragment length polymorphism (AFLP) and screened for toxin 
production [8, 9]. Heroin samples, citric acid and equipment thought to be associated with 
the outbreak were evaluated by various aerobic and anaerobic culture methods [10]. 
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Evaluation of an intervention strategy 
During the outbreak, methadone maintenance treatment (MMT) was promoted as an 
alternative to using potentially contaminated heroin or related materials. Outreach activities 
focused primarily on southwest Dublin, the area most affected by the outbreak. To assess 
the effectiveness of this campaign, the number of IDUs from southwest Dublin that enrolled 
into MMT was determined for the 4 months after the outbreak was recognized (i.e. June–
September 2000) and compared to data from the same period of time 1 year prior (i.e. 
June–September 1999). To determine treatment retention rates at 1 year for persons 
enrolled during the outbreak, registration data was also evaluated for June–September 
2001. 
Data analysis 
Data were collected on a standardized form and analysed using Epi-Info 2000 (CDC). 
Categorical variables were described as proportions and compared using the Mantel–
Haenszel χ2 or Fisher’s exact test. Continuous variables were described by the median and 
range and compared using the Kruskal–Wallis Wilcoxon rank sum test. 
RESULTS 
Patient demographics 
Between 1 April and 31 August 2000, we identified 22 IDUs in Ireland with severe injection-
site inflammation resulting in hospitalization or death; eight (36%) cases were fatal. The first 
patient was admitted to hospital on 2 May and the last presented on 26 June (Fig. 1). The 
case-fatality ratio varied over the course of the outbreak, dropping from 53% (8/15) for IDUs 
first hospitalized in May compared to 0% (0/7) for patients presenting in June (P = 0·02). 
The median age of case-patients was 30 years (range 19–51 years); 14 (64%) were male. 
In Ireland, all identified case-patients resided in the Dublin metropolitan area, including 14 
(64%) who lived in a single small neighbourhood in southwest Dublin. No cases were 
identified from several other areas in the city with large populations of known IDUs. 
 
 
Fig. 1. Cases of severe illness among injecting drug users by week of hospitalization, 
Ireland, 1 April to 31 August 2000, □,Non-fatal; ■, fatal. 
 
Clinical characteristics 
Many of the clinical observations among the Irish case-patients were similar to those seen 
among Scottish and English cases [11, 12]. The chief presenting complaint among most 
patients was soft-tissue infection of an injection site located on the buttocks (32%), groin 
(18%), thigh (18%), arm (14%), abdomen (9%), or an in-dwelling catheter site (5%). These 
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wound infections were characterized by oedema (86%), erythema (73%), pain (68%), 
necrosis (23%), pus (14%) and crepitus (5%). Six (27%) patients had accompanying 
lymphadenopathy noted. Among the 21 case-patients for whom data were available, there 
was a median of 5 days (range 0–14 days) between symptom onset and hospitalization. 
Systemic signs and symptoms at hospitalization included fever ≥38·0 °C (50%), altered 
mental status (32%), extreme thirst (23%), hypotension (18%), and nausea/vomiting (18%). 
Several important clinical features were not prominent findings among these patients. Few 
patients had a rash outside of the wound site. Thrombocytopenia, disseminated 
intravascular coagulation, liver failure and renal failure were also uncommon. Although a 
number of patients developed altered mental status, none had focal neurological changes 
indicative of botulism or tetanus. Finally, only two (9%) patients were known to be infected 
with human immunodeficiency virus (HIV), including one fatal and one non-fatal case; 10 
(45%) patients were known to be infected with hepatitis C virus, and five (23%) patients 
were known to be infected with hepatitis B virus. 
Although systemic symptoms were not prominent features at presentation, more than one 
third of the patients experienced a subsequent rapid deterioration including hypotension and 
cardiogenic shock, often despite surgical debridement and broad-spectrum antibiotics. 
Among the eight fatal cases, there was a median of only 1 day (range 0–7 days) from 
admission to death. Altered mental status (i.e. agitation or confusion) was noted in five 
(63%) of eight fatal cases, compared with only two (14%) of the 14 non-fatal patients 
(Fisher’s exact P = 0·05). The median WBC among fatal cases was 60 000 cells/mm3 (range 
8200–96 500 cells/mm3) compared with 11 950 cells/mm3 (range 2800–17 300 cells/mm3) 
for survivors (Kruskal–Wallis P = 0·02). One patient who subsequently died had a WBC of 
13 500 cells/mm3 at presentation and 81 700 cells/mm3 less than 24 h later, a pattern 
consistent with a leukaemoid reaction. HIV status, severity of wound site infection (e.g. 
necrosis or crepitus) and fever were not predictive of poor outcome. 
Of the eight case-patients who died, post-mortem examination of the injection-site wounds 
(i.e. skin, subcutaneous tissue, fascia and muscle) revealed swelling or oedema (75%) and 
pus or abscess formation (25%). All had evidence of pulmonary oedema. Other common 
systemic autopsy findings included large pleural and pericardial effusions (88%), 
subendocardial haemorrhage (63%), and hepatosplenomegaly (63%). As presented by Finn 
et al. [13] toxicological evaluation revealed that all fatal cases had narcotics, including 
methadone and free morphine present at either toxic or fatal levels; however, based on the 
history of habitual drug use, clinical presentations, and autopsy findings, drug overdose was 
not considered the likely cause of death. 
Patient and surrogate interviews 
Nineteen patients or their surrogates were available for interview. Of these, 14 (74%) 
injected heroin alone and five (26%) injected heroin and cocaine together. All injected with 
needles provided by the needle exchange, and all used citric acid to dissolve the heroin 
prior to injecting. Twelve cases (63%) claimed the heroin to be different by colour, 
consistency, and/or sensation upon injecting, and nine (47%) described the heroin to be 
harder to dissolve and required more citric acid than normal. Seventeen cases (89%) 
injected drugs into skin or muscle (i.e. popping) because of lack of available vein access, 
and two (11%) had failed intravenous injection (i.e. missed the vein) at the site of their soft-
tissue infection. 
Twelve (55%) of the case-patients interviewed could be directly or indirectly linked to a 
common supplier of heroin (Fig. 2). Furthermore, six (43%) of the 14 non-fatal patients were 
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family or close friends to those who died and had injected the same batch of heroin 
together. These patients claimed to have sought treatment earlier than they would have 
normally because of the dramatic decline and death of their injecting partner. 
 
 
 
Fig. 2. Potential links to a common supplier of heroin for 12 (55%) of the 22 cases identified 
in Ireland between 1 April and 31 August 2000. * C. novyi isolated from clinical specimens. 
 
Laboratory findings 
Specimens from the injection-site wound were available for diagnostic testing on 11 (50%) 
of the 22 patients identified, including five (63%) of eight fatal cases and six (43%) of 14 
non-fatal cases. Based on results from all laboratory sites, nine (81%) of the 11 patients had 
one or more well-described aetiologies of soft-tissue infection among IDUs identified, 
including Clostridium novyi (n = 2), Staphylococcus aureus (n = 3) and S. aureus and β-
haemolytic streptococcus (n = 3) (Table 1). Two additional patients had abundant Gram-
positive rods identified from the wound site, but tissue was not available for culture and a 
single organism could not be discerned by 16S rDNA PCR on fixed specimens. Further 
confounding the process of defining an aetiology, six (55%) of the 11 patients also had ≥1 
organism isolated that are less commonly associated with wound site infections, including 
Enterococcus spp. (n = 1), peptostreptococcus (n = 1), Escherichia coli (n = 1), Candida 
albicans (n = 1), and mixed flora (n = 1). There was no evidence of Bacillus anthracis in any 
specimens tested. 
Table 1. Microbiological findings from wound-site specimens among injecting drug users 
with severe illness or death, Ireland, April–August 2000 
 Fatal cases (n=5) Non-fatal cases (n=6) 
 n (%) n (%) 
Clostridium novyi* 2 (40) 0 (0) 
Staphylococcus aureus# 1 (20) 5 (83) 
Mixed flora$ 0 (0) 1 (7) 
No organism identified 2 (40) 0 (0) 
* One patient had C. novyi isolated from the wound site as part of a mixed culture that included 
peptostreptococcus, enterococcus, Bacillus fragilis and Curvularia. 
# All six patients with evidence of infection due to S. aureus had another organism isolated from the 
wound site including group C streptococcus (2), group B streptococcus 
(1), a-haemolytic streptococcus (1), Enterococcus spp. (1) and Candida albicans (1). 
$ One non-fatal case had mixed flora isolated from the wound site that included Clostridium 
argentensis, Clostridium subterminale, Enterococcus spp., and Curvularia. 
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Despite the variable and polymicrobial findings, there was evidence that two of the more 
severe infections were attributable to toxin-producing C. novyi. Both patients with evidence 
of C. novyi infection died, and both were epidemiologically linked to a common supplier of 
heroin. The one isolate available for testing showed evidence of toxin production by mouse 
and Vero cell biotoxin assays. This isolate was identified as type A by conventional and 16S 
rDNA sequencing and was identical by AFLP to 15 C. novyi type A isolates obtained from 
IDUs in the United Kingdom during the outbreak period [9]. By contrast, only one (17%) of 
the six patients with evidence of S. aureus or β-haemolytic streptococcus died. 
Adequate heroin samples were available for testing from only two patients, neither of who 
had clinical specimens for diagnostic testing; Clostridium perfringens was isolated from one 
heroin sample and a Bacillus spp. from the other. 
Intervention outcomes 
At the beginning of the outbreak, approximately 5000 heroin users were registered with 
methadone treatment centres in Dublin. Following a concerted effort to promote MMT as an 
alternative to using potentially contaminated heroin or related materials, 136 IDUs from 
southwest Dublin were enrolled into MMT between June and September 2000. By contrast, 
86 new users were enrolled from that neighbourhood during June–September 1999. After 1 
year, 77% of the individuals who enrolled during the outbreak period in 2000 remained in 
treatment, which is comparable to the retention rate seen among IDUs who enrol in MMT for 
any reason [14]. 
 
DISCUSSION 
Public health authorities faced several unique challenges in the investigation of this 
outbreak. Distinct characteristics of the IDU population created multiple obstacles including 
(1) the initial detection of the outbreak and the aetiological agent, (2) identifying risk factors 
for infection, and (3) designing an appropriate intervention strategy. IDUs have high rates of 
morbidity and mortality due to soft-tissue infection, other infectious diseases such as HIV 
and viral hepatitis, and overdose [15–17]. A review of Dublin coroners’ records identified that 
84 opiate-related deaths occurred during 1999 [18]. At that time, Dublin had a population of 
1·1 million with an estimated 13 000 IDUs [19]. While limited to 1 year of data, these results 
suggest that the high background of opiate-related deaths may have precluded identifying 
this cluster by a review of overall mortality among IDUs. As a result, detection of this 
outbreak was highly dependent on astute observations of clinicians and pathologists, in 
combination with the temporal association with similar clusters of severe illness and death 
among IDUs in the United Kingdom [1, 3, 4, 20]. 
Identification of an aetiological agent was hampered by several factors, including the high 
prevalence of soft-tissue infection in this population. Previous studies among IDUs have 
demonstrated a prevalence of soft-tissue infections or cellulitis of up to 32% [16, 21]. Given 
the already elevated rate of injection-site infections in this population, the use of a non-
specific clinical case-definition may have resulted in the detection of sporadic cases that did 
not involve C. novyi infection. S. aureus and Streptococcus spp., both well-recognized 
causes of soft-tissue infection among IDUs, were isolated from 27% of Dublin case-patients. 
In addition, the presence of toxic and fatal levels of narcotics in all of the deaths in Ireland 
raises the question of a possible contribution of high drug levels to fatal outcome [13]. 
However, despite these confounding factors, 17% of case-patients in Ireland and the United 
Kingdom had evidence of infection with C. novyi type A, isolates of which were 
indistinguishable by AFLP [22]. This microbiological evidence, in combination with the 
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distinct clinical findings, suggest that C. novyi was the causative agent of severe illness in at 
least a subset of case-patients. 
Further complications were encountered in the process of the epidemiological investigation. 
Case-patients and surrogates were often concerned about disclosing information regarding 
their activities or the source of their heroin for fear of their safety and the possibility of 
criminal prosecution. However, during the interview process, we were able to link 12 of the 
22 case-patients to a common supplier of heroin. Six of the 12 linked case-patients died, 
including the two fatal cases with evidence of C. novyi infection (cases 4 and 8). This 
traditional epidemiological approach can provide further evidence that a subset of case-
patients shared a common source of potentially contaminated heroin. This type of approach 
or findings were not available for the investigations in Scotland and England [13, 14]. 
Risk behaviours, such as needle-sharing and skin-popping may be practised by many IDUs, 
leading to possible confounding in epidemiological analyses. Despite these challenges, 
evidence from a case-control study comparing Dublin case-patients to IDUs with no recent 
history of soft-tissue infection demonstrated that injection into skin or muscle was an 
independent risk factor for being a case-patient [23]. A case-control study of the Scottish 
cases identified injection into the skin or muscle and using a filter shared with someone else 
as variables strongly associated with illness [24]. Similar injecting behaviour was also 
evident among case-patients from England [11]. Injection into skin or muscle has been 
associated with outbreaks of other clostridial infections such as botulism and tetanus. In 
these outbreaks, investigators surmised that tissue damage resulting from skin-popping may 
have generated an anaerobic environment ideal for the development of clostridial infections 
[25–28]. 
Limitations in laboratory diagnosis and specimen collection were additional challenges to the 
public health investigation. Clostridia are highly fastidious, Gram-variable organisms that are 
difficult to grow and identify under standard diagnostic conditions. This may have interfered 
with identification at local microbiology laboratories. Specimens from the injection-site 
wound were only available for 50% of case-patients, precluding laboratory evaluation for a 
possible aetiology. Delays in autopsies on fatal cases, particularly early in the outbreak 
period may have resulted in significant post-mortem contamination, making the 
interpretation of culture and other laboratory results difficult. 
In an effort to improve case-finding, management and laboratory diagnosis, a variety of 
interventions were implemented. Rapid initial clinical improvement was seen in case-
patients who received high-dose therapy with antimicrobials with known effectiveness 
against anaerobes (e.g. clindamycin). Health alerts recommended that drug users with 
injection site wounds be evaluated and treated as early as possible. Recommended 
treatment included surgical debridement and culture of any injection-site infection, and the 
use of antibiotics with good anaerobic activity as part of empiric therapy. Microbiology 
laboratories optimized procedures for the isolation and identification of anaerobic bacteria. 
No additional cases were identified after 26 June 2000 and a significant decrease was seen 
in the case-fatality ratio among case-patients presenting in June compared to those 
presenting in May. These findings demonstrate that interventions may have had some 
beneficial effect. However, the depletion of contaminated heroin, and the effect of earlier 
hospital presentation by cases occurring later in the outbreak may have also contributed to 
the decline in case fatality over time. 
MMT was widely promoted as a means to avoid heroin use since it was felt that harm 
reduction strategies such as skin cleansing or syringe exchange may not have been 
adequate interventions given the suspected contamination of heroin or related materials. 
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While motivating behavioural change among IDUs is typically challenging, a significant 
increase in the number of new enrolees into MMT was seen following the outbreak period in 
2000. This may have been due in part to an aggressive outreach effort, although reasons for 
enrolment were never ascertained. Whether or not outreach activities were effective among 
IDUs at highest risk (i.e. those reporting skin-popping) cannot be determined. Approximately 
40–50% of IDUs who have enrolled in MMT in other settings have reported continued heroin 
use despite treatment [14], however, the proportion of Dublin MMT enrolees that completely 
abstained from heroin use during their enrolment is not known. In addition, five of the eight 
deaths (63%) had detectable levels of methadone on autopsy toxicological evaluation, 
suggesting that case-patients may still have been at risk for infection from injecting despite 
the concurrent use of methadone [13]. There has been a gradual but steady increase in the 
provision of MMT in Dublin from 1800 at the end 1996 to 6500 at the end 2003 (J. Barry, 
personal communication). Thus, it is difficult to interpret the increase in localized recruitment 
between 1999 and 2000. Likewise examination of trends in other markers such as drug 
deaths and prevalence estimates casts no light on reasons for the increased recruitment 
into MMT. 
In Scotland, community intervention primarily involved promoting risk reduction [12] as 
opposed to enrolment in MMT. For example, users were encouraged to smoke heroin 
instead of injecting. If injecting heroin was unavoidable, users were advised not to inject into 
skin or muscle and to reduce the amount of acid utilized. This approach differed from the 
Irish effort to promote MMT enrolment, the impact of which we have attempted to measure. 
It is unknown whether one approach was more successful over the other with regard to 
reducing the risk of severe illness and infections related to this outbreak. 
The need to coordinate activities among a wide array of local, national and international 
laboratories and health agencies and law enforcement presented logistical challenges. A 
simultaneous criminal investigation was being conducted by the Garda National Drug Unit. 
Collaboration between law enforcement and public health in such an investigation was a 
novel activity. Law enforcement regulations required additional logistical steps in the 
handling and transportation of clinical specimens and heroin or other drug-related samples. 
All specimens and samples were considered evidence and had to follow a chain of custody 
procedure. Special licenses and permits were required for transportation to international 
reference laboratories. 
At the time of this outbreak, clusters of unexplained illness were not reportable to Irish public 
health authorities. Without full investigative authority, case finding, medical record review, 
patient interviews and clinical and environmental specimen collection were often difficult. 
Regulations have now been amended for the reporting of infectious diseases in Ireland, and 
effective from 1 January 2004, unusual clusters or changing patterns of illness of public 
health concern must be reported to health authorities. This legislative change will help 
prevent delays in identification and investigation of future disease outbreaks. Furthermore, 
electronic disease reporting from emergency departments was not in place at the time of 
this outbreak. Implementation of an electronic surveillance system would potentially 
decrease the time to recognition of a cluster of unexplained illness and consequently should 
be addressed as a priority. 
Between 2000 and 2004, there has been a dramatic increase in illness caused by spore-
forming bacteria (Clostridium and Bacillus spp.) in IDUs in the United Kingdom, and reasons 
for this trend are unclear [28]. Understanding the unique medical, legal, and public health 
challenges faced when investigating these types of outbreaks will allow public health 
authorities and the medical community an opportunity to plan for future occurrences. 
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